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The first 2 issues of Prescriptions for
Excellence in Health Care addressed quality
improvement in general terms (“Doing
Things Right and Doing the Right Things
– Quality and Safety in Health Care,” Fall
2007) and from the hospital’s perspective
(“Hospitals Take Ownership for Quality
Improvement and Patient Safety,”
Winter 2007). In this issue, we feature
innovative strategies for improving quality
of care in 4 different clinical settings.
Pay for performance (P4P) continues
to have both advocates and detractors.
Although the Centers for Medicare and
Medicaid Services (CMS) and other
organizations have promoted P4P as a
tool for improving the quality of patient
care, there remains little evidence to
support its effectiveness at this juncture.
The first article, “Effectiveness of Pay for
Performance as a Quality Improvement
Strategy,” chronicles a study comparing and
contrasting the impact of P4P vs. public
reporting vs. governance and oversight on
specific measures of clinical quality in a large
health care system – with surprising results.
The second article, “Heart Failure
Advocates Reduce Hospitalizations and

Readmissions for Heart Failure,” describes
an innovative strategy whereby nonadvanced practice nurses were trained
and deployed at 6 different hospitals to
promote guideline-based care. The success
of this program spurred the development
of a National Heart Failure Training
Program for heart failure advocates.
An electronic health record was put to the
test as a positive change agent in a study
intervention targeting lipid management.
“Lipid Management Study Shows
Value of Electronic Health Records in
Improving Quality of Care,” the third
article, describes this randomized controlled
study and discusses the outcomes.
“Ambulatory Quality Measurement:
The Jefferson University Physicians
Experience,” the fourth article, details
the development and implementation
of a faculty-practice-wide ambulatory
quality measurement initiative at our own
institution. After 2 years of activity, 14
of the 16 Jefferson University Physicians
( JUP) clinical departments had at least 1
performance measurement initiative under
way. In addition, JUP became one of the
first academic group practices to deploy an
ambulatory patient safety assessment tool.
Prescriptions for Excellence in Health
Care is brought to Health Policy
Newsletter readers by the Department
of Health Policy in partnership with
Eli Lilly and Company to provide
essential information from the quality
improvement and patient safety arenas.
(continued on page 2)
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The Importance of HIT
By Alex Azar
Health information technology
(HIT) is generating a great
deal of interest in the health
care industry. Theoretically,
it gives us the ability to
coordinate all existing medical
knowledge about a patient
and to incorporate new
information on a real-time
basis. By amassing relevant
data electronically from many
different sources (eg, drug
companies’ clinical trials,
health insurers’ claims data,
and physicians’ documentation
of patients’ medical histories),
HIT could allow us to
know more about patients
more quickly and in greater
detail than ever before.
As is often the case, theory
is not easily translated into
practice. Individual providers
have been slow to adopt new
technology, and we have
yet to develop the level of
systems integration necessary
for high-level information
exchange. In the next issue
of Prescriptions for Excellence,
this column and the feature
articles will highlight HIT
applications with a focus on
positive solutions to benefit
patients, physicians, and
the industry as a whole.
Alex Azar is Senior Vice
President for Corporate Affairs
and Communications at
Eli Lilly and Company

(continued from page 1)

on a second series of newsletters.

The final issue in this series of
Prescriptions for Excellence in Health
Care will be devoted to the role of
health information technology and
public reporting in improving quality
and safety. Finally, I am pleased
to report that the response to this
series has been very positive and that
Lilly has agreed to partner with us

As always, I am interested in your
feedback and you can reach me by
email at david.nash@jefferson.edu.
David B. Nash, MD, MBA is the
Dr. Raymond C. and Doris N. Grandon
Professor of Health Policy and Chairman
of the Department of Health Policy
at Jefferson Medical College.

Effectiveness of Pay for Performance as a Quality
Improvement Strategy
By Stephen R. Grossbart, PhD
Background
Catholic Healthcare Partners (CHP)
is the largest health care provider in
Ohio, with other hospitals located in
Kentucky, Pennsylvania, and Tennessee.
It is organized into 9 regional service
areas in 5 states and includes 29
hospitals. When, in July 2003, Health
and Human Services (HHS) Secretary
Tommy G. Thompson announced a
hospital-based pay-for-performance
(P4P) demonstration project involving
Premier, Inc., hospitals in CHP’s
network had to decide whether or
not to participate. Because Premier,
Inc. required that hospitals renew a
subscription to a relatively expensive
database tool as a condition for
participation, cost was a limiting factor.
Even if small-volume hospitals
attained the highest performance
ratings, they would not earn
sufficient bonuses to offset the cost
of the Premier database and the
additional staff required to support
data abstraction. Ultimately, each
of 4 regional health systems within
the CHP network volunteered to
have its largest volume facility join
the project. These systems believed
that P4P was inevitable and saw

the project as an opportunity to be
better prepared for payment reform.
CHP recognized the opportunity to
study the impact of public reporting,
P4P, and governance oversight on quality
improvement in a multihospital system
by comparing the P4P participants
with a set of similar CHP hospitals that
did not join the demonstration project.
The study tested the question: Did
hospitals participating in the Center for
Medicare and Medicaid Services’ (CMS)
“Premier Hospital Quality Incentive
Demonstration Project” have significantly
different rates of improvement in the
quality of care delivered compared
to similar hospitals within the same
system that did not participate in the
voluntary demonstration project over
the course of the 3-year project?
Study design
The study compared the impact of 1)
the Premier Demonstration, 2) public
reporting through the Hospital Quality
Alliance (HQA), and 3) the evolving role
of governance oversight, with particular
attention to assessing the long-term
impact of the Premier Demonstration
project relative to internal and other
external drivers of quality improvement.
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Study results
The 4 hospitals participating in the P4P
demonstration project had significantly
higher composite quality scores in each
of the 3 clinical areas studied in Year 1 of
the demonstration; however, by Year 3,
the added pressure for public reporting
of performance coupled with corporate
goals requiring all hospitals in the
system to be accountable at leadership
and governance levels, eliminated
the significant differences that once
separated the 2 cohorts (Figure 1).
Baseline
In the baseline year (2003), the 2
cohorts had similar rates of overall
performance, with participating
hospitals starting at 80% and
nonparticipating hospitals at 79%.
Year 1
In 2004, participant hospitals improved
their performance in HF and increased
their overall composite quality scores to
90% (vs. 86% for nonparticipants). The
Year 1 rate of increase for participants
(9.8%) was significantly better than the
nonparticipant rate (6.7%) (p= <.001).
This difference was attributed primarily
to HF care, where improvement from
baseline to Year 1 for participating

Figure 1. Overall Composite Quality Score for HQA Measures for AMI, HF, and PN,
Catholic Healthcare Partners: CMS/Premier HQID Participants vs. Non-Participants
2003: Baseline

100%

2004: Year 1

2005: Year 2

2006: Year 3

95%
90%

Composite Quality Score

Within a single health care system, a
test group of 4 acute care hospitals that
participated in the demonstration project
in federal fiscal years (FFY) 2004-2006
was compared to a control group of
5 hospitals that did not participate in
the project. The study limited analysis
to 3 clinical areas that are included in
the Premier Demonstration: 1) acute
myocardial infarction (AMI), 2) heart
failure (HF), and 3) pneumonia (PN).
Performance was compared to a baseline
year (2003) for both participating and
nonparticipating hospitals to determine
if the rate of improvement differed
between the 2 cohorts of hospitals
over the following 3 years based on a
composite opportunity quality score.
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hospitals was 19% vs. 11% for
nonparticipating hospitals (p= <.001).
Year 2
In 2005, CHP expanded its internal
accountability for quality performance at
all hospitals in the system by including all
measures in the Premier demonstration
for AMI, HF, and PN with the goal of
achieving a top quartile ranking in the
3rd quarter. Composite scores achieved
by the 4 participating hospitals and the
nonparticipating hospital group were 92%
and 90% respectively. The demonstration
project hospitals had only a 2.6%
increase in performance, significantly
lower than the nonparticipant group,
which improved by 4.4% (p= <.001).
Year 3
By year 3, the difference in performance
between the 2 cohorts had narrowed
and the pace of improvement was
virtually identical. This was fueled
in part by the increased internal
accountability (ie, expansion of CHP
performance measurements) and higher
levels of expected performance.

Participants in the project achieved an
overall composite quality score of 95%
(2.7% improvement over Year 2) and
nonparticipants improved their composite
score by 3.5% to 94% (p= .015).
Over the course of 3 years, performance
of the 2 groups of hospitals converged.
Participants in the demonstration
project improved their overall composite
quality score by 15.1% compared to
14.6% for nonparticipants (p= .543)
over the 3-year period (Figure 2).
Conclusion
Although the P4P demonstration clearly
accelerated performance by participant
hospitals in the first year of the project,
performance by nonparticipants
exceeded the performance of participants
in years 2 and 3. Both cohorts of
hospitals performed at identical levels
by 2006. While nonparticipants had
greater opportunity for improvement, the
significant drivers of public reporting and
internal focus on quality improvement
(continued on page 4)
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Stephen R. Grossbart, PhD is Vice President
for Quality Management at Catholic
Healthcare Partners. He can be reached at:
srgrossbart@health-partners.org

Figure 2. Overall Composite Quality Score for HQA Measures for AMI, HF, and PN,
Catholic Healthcare Partners: CMS/Premier HQID Participants vs. Non-Participants
100%

Composite Quality Score

(ie, tying senior executive accountability
to performance on quality indicators
and board oversight of corporate quality
objectives and goals) created a strong
environment for improvement.
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Heart Failure Advocates Reduce Hospitalizations and Readmissions for Heart Failure
By Donald E. Casey, Jr, MD, MPH, MBA, FACP
Randomized clinical trials
and observational studies have
demonstrated the positive effects
of multidisciplinary teams on heart
failure (HF) readmissions. Many
believe that such teams require the
presence of an advanced practice
nurse specializing in HF. Catholic
Healthcare Partners (CHP)
demonstrated that the deployment
of Heart Failure Advocates (HFA),
non-advanced practice nurses
specially trained to promote
guideline-based care, can result in
significant reductions in both HF
hospitalizations and associated costs.
HFA Initiative
In 2004, an initial cohort of 6 HFAs
were recruited, trained, and deployed
in 6 different CHP hospitals in
different geographic locations. The
training was based extensively upon
current clinical practice guidelines
for HF published by the American
Heart Association (AHA) and the
Heart Failure Society of America.

1. Evidence-based approaches to
medication adherence and
management, especially for
angiotensin-converting enzyme
(ACE) inhibitors /angiotensin receptor
blockers (ARB) and beta-blockers

Results and discussion
Initial analysis showed that the “sickest”
patients admitted with DRG (diagnosisrelated group) 127 and enrolled under
the care of the HFAs experienced
fewer readmissions and longer intervals
between admissions than HF patients
who received the usual care.

2. Development of new and extensive
patient-centered care coordination
skills not currently part of traditional
hospital case management, with
special emphasis on post-discharge
telephonic follow-up, communication
with physicians responsible for
subsequent outpatient care post
hospitalization, and doing “whatever
it takes” to improve patients’ quality
of life through self-management

Further analysis revealed that patients
under the care of HFAs experienced a
66% reduction in hospitalizations with
a 41% reduction in all-cause 30-day
readmissions when compared with
other HF patients who were not cared
for by HFAs. On a quarterly basis, the
30-day all-cause readmission rate for HF
patients cared for by HFAs consistently
ranged between 1% and 10%, compared
to national readmission rates of 20%.

3. Special organizational skills,
such as leadership, influence, clinical
and administrative credibility
(especially with physicians and
hospital CEOs), creative problem
solving, and conflict resolution.

Enrollment of HF patients in the
HFA program had a strong effect on
readmissions. Days elapsed without
readmissions doubled in the postenrollment period (469 days) compared
with the pre-enrollment period (211

Elements of the HFA training included:
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days). The HFA patients experienced
fewer admissions and longer periods
of time without readmissions. This
translates into improved health status
and lower costs. See Table 1 and
Figure 1 for more analysis of results.

Table 1. Analysis of 30- and 60-day Readmissions for Heart Failure Patients:
Comparisons between Heart Failure Advocates and Usual Care
All Cause Readmission
Advocate
Control
30-day readmissions per patient
Patients with at least one 30-Day Readmission
60-day readmissions per patient

Lessons learned
1. Many nonacademic health
systems do not have direct
access to nationally recognized
clinical expertise for HF.
Such access can make a
huge difference in quality
improvement efforts.
2. Appropriate organizational
goals and incentives based
upon standardized quality
measurements (ie, American
College of Cardiology [ACC]/
AHA) are powerful motivators
for promoting and improving
quality. Standardized
“tools” are less important.
3. Making the transition from
focusing on acute hospital
management to reducing hospital
readmissions for HF is difficult and
currently not profitable for most
hospital systems; currently hospitals
must focus more on chronic care.
4. Significant expertise in
evidence-based HF care can

Patients with at least one 60-Day Readmission
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0.19

15.79%

13.83%

14.66%

5.66%

0.29

0.33
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Heart Failure Readmission
Advocate
Control

%
Difference

0.03

0.05
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3.65%

Figure 1: Kaplan Meier Curves for 30-day Readmissions for Patients with Heart Failure:
Comparisons between Heart Failure Advocates and Usual Care
Survival Distribution Function

Because of the remarkable success of
this intervention, CHP partnered with
the National Heart Failure Training
(NHeFT) Program to develop a
nationally available program for training
nurses to become HFAs. Specially
trained nurses without advanced practice
degrees can have a significant impact on
avoiding hospitalizations for patients with
HF. Although this training program
is in the early stage of implementation,
hospitals interested in developing a HFA
program are strongly encouraged to
participate in the NHeFT Program.
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Donald E. Casey, Jr, MD, MPH, MBA,
FACP is Vice President for Quality and Chief
Medical Officer of Atlantic Health, Morristown,
NJ. He is the former Chief Medical Officer for
Catholic Healthcare Partners. Dr. Casey can
be reached at: don.casey@atlantichealth.org.

Lipid Management Study Shows Value of Electronic
Health Records in Improving Quality of Care
By James Gill, MD, MPH
Despite evidence that controlling
cardiovascular risk factors reduces
cardiovascular disease morbidity
and mortality in persons with and
without coronary heart disease,
research has shown that physicians in
clinical practice often do not follow
national guideline recommendations
for the detection and treatment of
hyperlipidemia.1-3 In addition to
promoting better organization of
patient data such as medications and
test results, studies have concluded that
computerized systems, including the
electronic health record (EHR), can
aid in improving the quality of care by:

• Providing automated reminders
of needed tests.4
• Highlighting detection/treatment
guidelines during office visits.5
Although several studies showed
improvement in lipid testing when
EHR aids were used, few examined
the impact of the EHR on lipid
control (ie, test outcomes).
Study design
To better determine the benefits of
EHRs in lipid management, researchers
(continued on page 6)
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(continued from page 5)
conducted a randomized, controlled
study to examine the impact of
an EHR-based intervention for
lipid management in a network
of primary care practices. The
intervention integrated nationally
recognized Adult Treatment Panel
III (ATP-III) guidelines from the
National Cholesterol Education
Program (NCEP) at the point of
care using the EHR. The hypothesis
was that patients of physicians at
the intervention offices would be
more likely to have up-to-date lipid
testing, to be at their lipid goal, and
to be on medications if not at goal
than patients at nonintervention
offices (control group).
The study’s primary focus was to
determine whether the intervention
group showed greater improvement
than the control group on 4 main
outcome measures: (a) lipids at goal, (b)
lipid testing completed, (c) appropriate
use of lipid medications in highrisk patients, and (d) lipid diagnoses
recorded. The study included 25
primary care practices within the
Medical Quality Improvement
Consortium (MQIC), which uses
the Centricity® outpatient EHR and
regularly downloads de-identified
clinical data into a secure central
repository. All active patients,
ages 20 to 79, for each of the 105
participating physicians were included
and categorized as high, medium,
or low risk based on modified ATPIII criteria. Overall, there were
64,150 patients in this study with
26,696 in the intervention group
and 37,454 in the control group.
Study intervention
An interactive, point-of-care EHR
disease management tool was integrated
into the physician’s usual EHR encounter
form in the following manner:

• The screening page appeared
during a patient visit if
lipid testing was overdue or
if lipid goals were not met.
• The assessment page highlighted
the patient’s lipid goal and
whether or not he/she met that
goal, using information from the
EHR. The physician could modify
that information (and possibly
change the patient’s lipid goal)
and/or access more information
on the ATP-III criteria.
• The management page allowed
the physician to add or change
medications, order lab tests,
print patient education handouts,
and document counseling,
as well as directly access Web
sites for physician or patient
education about hyperlipidemia.
The intervention employed other
reporting tools to identify patients
who were not seen in the office and
who did not meet lipid management
criteria. These tools generated lists
of patients who had not been recently
tested for hyperlipidemia or were
not at goal for lipid management,
and provided personalized letters for
physicians to send to these patients.
Intervention offices were asked to run
these reports once at the beginning of
the study and again after 6 months.
Outcome Variables
The 3 main outcome variables were:
• Proportion of patients tested
adequately for hyperlipidemia
(a full lipid panel within 1
year for persons at high risk, and
within 5 years for all others);
• Proportion of patients whose
most recent low-density
lipoprotein cholesterol (LDL-C)
was at goal (<100 for high risk,

<130 for moderate risk, and
<160 for low-risk patients);
• Proportion of high-risk patients
with an LDL-C >130 who were
prescribed lipid-lowering
medications. Patients with no
LDL-C or whose LDL-C was
nonnumerical (eg, “unable to
calculate” or “normal”) were
excluded from the analyses of
lipids at goal and medication use.
Results and Discussion
Results showed that the likelihood
of achieving the desired outcomes
increased significantly from baseline
to end point for all groups, with few
exceptions. However, the increases
were generally modest; the largest
increase (7%) was in the likelihood
of high-risk persons being on lipidlowering medication if their lipids
were not at goal. Of interest, the
increases were observed equally in
the intervention and control groups.
After controlling for differences in patient
and physician characteristics between
the 2 groups and for the “clustering”
effect, the only outcome for which the
intervention group showed a significant
improvement was lipid testing for highrisk patients. These results are surprising
given that EHR interventions have been
shown to improve preventive care. The
researchers cited possible reasons for
the marginal differences between the
intervention and control groups 1 year
after implementing the EHR-based
disease management intervention:
• The Hawthorne effect (ie,
persons who know their behavior
is being observed may be more
likely to improve that behavior);
• Potential for similar quality
improvement interventions
implemented within the control
group during the study period (eg,
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managed care disease management
initiatives);
• High baseline parameters that left
little room for improvement (Note:
rates in this study were higher than
those found in previous studies);
• Physicians, in general, approaching
lipid management more aggressively
than in previous study periods;
• Lack of office staff involvement in
the intervention.
Despite the relatively small increase
in quality of care reflected in the
study, most physicians surveyed said
they found the intervention both
helpful and useful in their practices.
Conclusion
Researchers concluded that, although
EHRs are useful tools, they are not a
panacea for improving quality without
changing other components of usual
office care. They suggest that future
studies may need to examine more
comprehensive interventions that include
office staff in a team approach to care.
James Gill, MD, MPH is President of Delaware
Valley Outcomes Research and Associate Professor
in the Department of Family and Community
Medicine at Jefferson Medical College. He
can be reached at gillj@devoresearch.com.
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Ambulatory Quality Measurement:
The Jefferson University Physicians Experience
By Neil I. Goldfarb
Historically, quality measurement and
improvement in ambulatory care was
undertaken at the health plan level.
Thanks to the standardized Health
Plan Employer Data and Information
Set (HEDIS®) measurement set,
emphasis is increasingly being placed
on measuring quality at the level
of the individual provider group or
provider. As measures are developed,
pilot tested, and disseminated, they are
fueling quality improvement and valuebased purchasing initiatives such as
• public reporting of providerlevel quality data,
• consumer incentives for choosing
higher quality providers,
• selective contracting with
higher quality providers, and
• pay-for-performance (P4P)
programs for ambulatory
care providers.
Jefferson University Physicians ( JUP),
the faculty practice plan of Thomas
Jefferson University, consists of over 400
physicians in primary care and specialty
care practices. As a large multispecialty
academic group practice, JUP faces
many challenges in ensuring that quality
care is provided consistently across all
practice sites and providers. A survey
conducted in 2003 found that JUP and
most of its colleagues in the University
HealthSystem Consortium were just
beginning to recognize the need to
address ambulatory care quality.1
In 2004, JUP reconstituted its Clinical
Care Subcommittee (CCS) as the main

oversight body for ambulatory care quality
measurement and improvement. The CCS
includes representation from all clinical
departments. JUP leadership agreed to
fund a full-time quality review nurse and a
half-time data analyst to support the CCS’
work. Additional resources were provided
in-kind from Jefferson Medical College’s
Department of Health Policy, including the
Department’s Chair, who agreed to Chair
the CCS, and the Department’s Director of
Research, who assumed the responsibility
of JUP Director of Ambulatory Care
Performance Improvement.
Initially, the CCS focused on supporting
each of the 16 clinical departments
in developing and implementing at
least 1 outpatient quality measurement
activity. The CCS staff met with
representatives of each department to
discuss possible measures and provided
information on existing specialty-relevant
measures (eg, HEDIS or HEDIS-like
measures), specialty society guideline and
measurement development efforts, and the
emerging measurement sets endorsed by
the National Quality Forum and the AQA
Alliance. Where well-established measures
did not exist or did not seem relevant to the
practice, the practice representatives were
asked to propose measures based on criteria
of importance to the practice, feasibility of
measurement, and the belief that a quality
issue might exist in the area of study.
Nearly all departments were highly
receptive to this performance
measurement initiative and, within
the first 2 years of activity, 14 of 16
departments had at least 1 initiative under
way. Examples of projects include:
(continued on page 8)
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(continued from page 7)
• Measuring blood pressure control
for patients with hypertension
in the Internal Medicine and
Family Medicine practices
• Using the SF-12 (www.iqola.
org/instruments.aspx) survey
tool to measure health-related
quality of life (outcomes) for
patients in the Rehabilitation
Medicine outpatient practice
• Reviewing records for patients who
were seen in the Emergency
Department (ED), returned to the ED
within 72 hours, and were admitted to
the hospital, in order to determine if a
quality-of-care problem occurred
during the initial visit
• Surveying patients who underwent
ambulatory surgery to identify
postoperative infection rates and
other complications
• Tracking follow-up on biopsies
and time to patient notification
in the Dermatology practice
One major initiative, designed by the
Otolaryngology Department with
support from the CCS staff, examined
documentation of smoking history
and smoking cessation counseling for
patients with head and neck cancers.
Several rounds of measurements and
feedback to providers in this practice,
including redesigned charting tools and
patient education materials, resulted in a
marked improvement in history taking,
counseling, and referring patients who
continued to smoke. This project is being
expanded into a major public health
initiative spanning all departments.
JUP is one of the first academic group
practices in the nation to deploy the
Physician Practice Patient Safety Assessment
(PPPSA), an ambulatory patient safety
assessment tool developed by the Medical
Group Management Association, the

Institute for Safe Medication Practices, and
the Health Research & Educational Trust
(www.physiciansafetytool.org).
The tool is being completed by a
multidisciplinary team within each
practice site to identify potential areas
for safety improvement in domains
such as medication safety, patient
handoffs and transitions, and practice
management and culture. In addition
to helping departments identify areas for
improvement, the responses will be used to
compare JUP performance against national
benchmarks, identify best practices across
JUP departments, and identify areas for
JUP-wide safety improvement initiatives.
National measurement, reporting, and
P4P initiatives play an expanding role in
shaping the JUP quality measurement
and improvement agenda; eg, JUP is
participating in the Physician Quality
Reporting Initiative (PQRI) developed by
the Centers for Medicare and Medicaid
Services (CMS) (www.cms.hhs.gov/pqri/).
Viewed as the precursor to a federal P4P
program, PQRI is a pay-for-reporting
program in which practices may earn
bonus payments for reporting on quality
of care using a set of CPT-II (Current
Procedural Technology-II) codes. In
addition to familiarizing providers and
practice administrators with a new lexicon
and set of billing codes, implementation of
PQRI has required the development of new
billing forms to supplement existing ones.
Further complicating matters, other payers,
including the local Blue Cross Blue Shield
plan, have developed their own P4P systems
using a largely different set of measures.
An electronic medical record (EMR)
system, to be implemented in 2008, should
greatly facilitate the CCS team’s ability
to measure practice- and provider-level
performance efficiently, and to accurately
report performance data to CMS and
other payers. The CCS team is working
with the clinical departments and the
EMR implementation team to ensure that
record templates include essential fields for

quality measurement (eg, date of patient
notification of test results) and that these
fields will be linked with appropriate alerts
and flags (eg, reminders that patients have
not been notified of test results). Recent
CCS meeting discussions have focused on
how to use the EMR as a tool to promote
quality and how to dispel commonly
held beliefs that the EMR will solve all
the practices’ quality and safety issues.
Summary
Performance measurement and
improvement activities have advanced
rapidly within the JUP academic group
practice over the past 5 years. The
commitment of JUP leadership to
quality improvement is evidenced by
the continued dedication of financial
resources to the staffing of the CCS’
activities (funding increased from 1.5 to
2.0 FTE’s as of July 2007). While many
of JUP’s initial performance measurement
activities were home grown, the agenda
is shifting toward use of standardized
tools and participation in local and
national reporting and P4P programs.
Implementation of an EMR will
undoubtedly simplify some aspects of the
measurement and reporting processes, but
much work will be needed to determine
how best to deploy this tool for true quality
improvement. Participation in the national
University HealthSystem Consortium
and partnering with other organizations
at the local and national level are critical
to continued learning and development
and dissemination of best practices for
ambulatory group practice improvement.
Neil I. Goldfarb, Vice Chair for Research
in the Department of Health Policy at
Jefferson Medical College, is Director of
Ambulatory Care Performance Improvement
for Jefferson University Physicians. He can
be reached at: neil.goldfarb@jefferson.edu.
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